CanBas Co., Ltd. (TYO:4575)
Japan · Delayed Price · Currency is JPY 859.00
-12.00 (-1.38%)
At close: Feb 6, 2026
CanBas Market Cap
CanBas has a market cap or net worth of 16.42 billion as of February 6, 2026. Its market cap has decreased by -4.66% in one year.
Market Cap
16.42B
Enterprise Value
13.95B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
859.00
Market Cap Chart
Since September 18, 2009, CanBas's market cap has increased from 8.38B to 16.42B, an increase of 95.85%. That is a compound annual growth rate of 4.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 16.65B | 8.47% |
| Dec 30, 2025 | 15.35B | -10.38% |
| Dec 30, 2024 | 17.13B | 0.65% |
| Dec 29, 2023 | 17.01B | -5.30% |
| Dec 30, 2022 | 17.97B | 974.22% |
| Dec 30, 2021 | 1.67B | -48.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RaQualia Pharma | 26.14B |
| AnGes | 22.95B |
| Japan Tissue Engineering | 21.85B |
| Renascience | 19.28B |
| StemRIM | 17.61B |
| ReproCELL | 15.06B |
| Immuno-Biological Laboratories | 14.11B |
| Kubota Pharmaceutical Holdings | 12.69B |